Dian Diagnostics Group Co (SZSE:300244) Debt-to-Equity : 0.58 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Dian Diagnostics Group Co Debt-to-Equity?

Dian Diagnostics Group Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥1,799 Mil. Dian Diagnostics Group Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥2,556 Mil. Dian Diagnostics Group Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥7,498 Mil. Dian Diagnostics Group Co's debt to equity for the quarter that ended in Mar. 2024 was 0.58.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Dian Diagnostics Group Co's Debt-to-Equity or its related term are showing as below:

SZSE:300244' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.81 Max: 1.43
Current: 0.58

During the past 13 years, the highest Debt-to-Equity Ratio of Dian Diagnostics Group Co was 1.43. The lowest was 0.02. And the median was 0.81.

SZSE:300244's Debt-to-Equity is ranked worse than
70.47% of 193 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.22 vs SZSE:300244: 0.58

Dian Diagnostics Group Co Debt-to-Equity Historical Data

The historical data trend for Dian Diagnostics Group Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dian Diagnostics Group Co Debt-to-Equity Chart

Dian Diagnostics Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.85

0.88

0.75

0.81

0.55

Dian Diagnostics Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.80	0.67	0.57	0.55	0.58

Competitive Comparison of Dian Diagnostics Group Co's Debt-to-Equity

For the Diagnostics & Research subindustry, Dian Diagnostics Group Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dian Diagnostics Group Co's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dian Diagnostics Group Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Dian Diagnostics Group Co's Debt-to-Equity falls into.

Dian Diagnostics Group Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Dian Diagnostics Group Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1572.34	+	2619.611)	/	7566.265
	=	0.55

Dian Diagnostics Group Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1799.287	+	2556.435)	/	7497.593
	=	0.58

Dian Diagnostics Group Co (SZSE:300244) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Dian Diagnostics Group Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Dian Diagnostics Group Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Dian Diagnostics Group Co (SZSE:300244) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dian Diagnostics Group Co Ltd (SZSE:300244) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 329, Jinpeng Street, 5th Floor, Building 2, Xihu District, Zhejiang, Hangzhou, CHN, 310030

Website

http://www.dazd.cn

Dian Diagnostics Group Co Ltd is an independent third-party medical diagnostic service provider that provides diagnostic services outsourcing as its core business. It promotes the development of multi-service areas of medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains, covering medical diagnostic services and diagnostic products.

Dian Diagnostics Group Co (SZSE:300244) Headlines

No Headlines